Literature DB >> 31159584

Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067/ADAPT Study.

Tareerat Chemnasiri1, Anchalee Varangrat1, K Rivet Amico2, Anupong Chitwarakorn3, Bonnie J Dye4, Robert M Grant5, Timothy H Holtz1,6.   

Abstract

The HPTN 067/ADAPT Study evaluated the feasibility, acceptability, patterns of adherence and coverage for three randomly assigned oral FTC/TDF pre-exposure prophylaxis (PrEP) dosing regimens to prevent HIV infection. Using qualitative methods, we explored facilitators and barriers among a subset of men who have sex with men (MSM) participants in Bangkok, Thailand. Between August 2013 and March 2014, 32 HPTN 067/ADAPT participants joined in 6 focus group discussions, and 6 attended key informant interviews. Facilitators of PrEP adherence included use of strategies to have PrEP available when needed, simplicity in regimen requirements with recognition that more complex regimens may take some time to master, ability to plan for sex, receipt of social and technology support, ability to use a PrEP regimen that best matches to one's own patterns of sex, and experiences with PrEP as a part of health and well-being. Challenges to PrEP adherence included perceptions of no or low HIV risk, difficulties following regimens when intoxicated, concerns about side effects, experience of HIV stigma, and affordability of PrEP outside of study context influencing uptake and use in the community. Preferences for regimens varied, suggesting that multiple PrEP effective regimen options should be available to fit those with different needs.

Entities:  

Keywords:  HIV; PrEP; Thailand; men who have sex with men; young

Mesh:

Substances:

Year:  2019        PMID: 31159584      PMCID: PMC6889057          DOI: 10.1080/09540121.2019.1623374

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  19 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

Review 2.  Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.

Authors:  K Rivet Amico
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

3.  Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.

Authors:  Robert M Grant; Sharon Mannheimer; James P Hughes; Yael Hirsch-Moverman; Avelino Loquere; Anupong Chitwarakorn; Marcel E Curlin; Maoji Li; K Rivet Amico; Craig W Hendrix; Peter L Anderson; Bonnie J Dye; Mark A Marzinke; Estelle Piwowar-Manning; Laura McKinstry; Vanessa Elharrar; Michael Stirratt; James F Rooney; Susan H Eshleman; Janet M McNicholl; Frits van Griensven; Timothy H Holtz
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

4.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

5.  Temporal trends in HIV-1 incidence and risk behaviours in men who have sex with men in Bangkok, Thailand, 2006-13: an observational study.

Authors:  Frits van Griensven; Timothy H Holtz; Warunee Thienkrua; Wannee Chonwattana; Wipas Wimonsate; Supaporn Chaikummao; Anchalee Varangrat; Tareerat Chemnasiri; Wichuda Sukwicha; Marcel E Curlin; Taraz Samandari; Anupong Chitwarakorn; Philip A Mock
Journal:  Lancet HIV       Date:  2015-01-08       Impact factor: 12.767

Review 6.  Use of antiretrovirals for HIV prevention: what do we know and what don't we know?

Authors:  Jared M Baeten; Robert Grant
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

7.  Changes in sexual risk behavior among participants in a PrEP HIV prevention trial.

Authors:  Greg Guest; Dominick Shattuck; Laura Johnson; Betty Akumatey; Edith Essie Kekawo Clarke; Pai-Lien Chen; Kathleen M MacQueen
Journal:  Sex Transm Dis       Date:  2008-12       Impact factor: 2.830

8.  Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.

Authors:  K Rivet Amico; Michael J Stirratt
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

Review 9.  Microbicide clinical trial adherence: insights for introduction.

Authors:  Cynthia Woodsong; Kathleen MacQueen; K Rivet Amico; Barbara Friedland; Mitzy Gafos; Leila Mansoor; Elizabether Tolley; Sheena McCormack
Journal:  J Int AIDS Soc       Date:  2013-04-08       Impact factor: 5.396

10.  Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis.

Authors:  Kenneth Mayer; Brian Gazzard; José M Zuniga; K Rivet Amico; Jane Anderson; Yusef Azad; Gus Cairns; Nikos Dedes; Chris Duncombe; Sarah J Fidler; Reuben Granich; Michael A Horberg; Sheena McCormack; Julio S G Montaner; Helen Rees; Bruce Schackman; Papa Salif Sow
Journal:  J Int Assoc Provid AIDS Care       Date:  2013 May-Jun
View more
  6 in total

1.  Preferences for Conditional Economic Incentives to Improve Pre-exposure Prophylaxis Adherence: A Discrete Choice Experiment Among Male Sex Workers in Mexico.

Authors:  Aarón Salinas-Rodríguez; Sandra G Sosa-Rubí; Carlos Chivardi; Roxana Rodríguez-Franco; Monica Gandhi; Kenneth H Mayer; Don Operario; Nathalie Gras-Allain; Galileo Vargas-Guadarrama; Omar Galárraga
Journal:  AIDS Behav       Date:  2021-08-27

2.  Development of a digital pill and respondent behavioral intervention (PrEPSteps) for HIV pre-exposure prophylaxis adherence among stimulant using men who have sex with men.

Authors:  Peter R Chai; Yassir Mohamed; Georgia Goodman; Maria J Bustamante; Matthew C Sullivan; Jesse Najarro; Lizette Mendez; Kenneth H Mayer; Edward W Boyer; Conall O'Cleirigh; Rochelle K Rosen
Journal:  Transl Behav Med       Date:  2022-01-18       Impact factor: 3.626

3.  HIV PrEP services for MSM in China: a mixed-methods study.

Authors:  Chunqing Lin; Li Li; Jun Liu; Xiaobing Fu; Jun Chen; Wei Cao; Yan Li
Journal:  AIDS Care       Date:  2021-03-02

4.  Scales to Assess Knowledge, Motivation, and Self-Efficacy for HIV PrEP in Colombian MSM: PrEP-COL Study.

Authors:  Héctor F Mueses-Marín; Beatriz Alvarado-Llano; Julián Torres-Isasiga; Pilar Camargo-Plazas; Maria C Bolívar-Rocha; Ximena Galindo-Orrego; Jorge L Martínez-Cajas
Journal:  AIDS Res Treat       Date:  2021-09-07

5.  Effect of a Reminder System on Pre-exposure Prophylaxis Adherence in Men Who Have Sex With Men: Prospective Cohort Study Based on WeChat Intervention.

Authors:  Bing Lin; Jiaxiu Liu; Wei He; Haiying Pan; Yingjie Ma; Xiaoni Zhong
Journal:  J Med Internet Res       Date:  2022-08-11       Impact factor: 7.076

6.  A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.

Authors:  Janan Janine Dietrich; Nadia Ahmed; Emily L Webb; Gugulethu Tshabalala; Stefanie Hornschuh; Mamakiri Mulaudzi; Millicent Atujuna; Lynda Stranix-Chibanda; Teacler Nematadzira; Andrew Sentoogo Ssemata; Richard Muhumuza; Janet Seeley; Linda-Gail Bekker; Helen A Weiss; Neil Martinson; Julie Fox
Journal:  J Int AIDS Soc       Date:  2022-08       Impact factor: 6.707

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.